As of 22 Oct 2026, Promaxo has raised $5.6M across 2 verified rounds on record, plus 2 rounds still being checked; latest: $1.4 million strategic financing round, announced 7 Apr 2022.
A minimally-invasive and patient-centric MRI and robotic platform
promaxo.comLinkedInOakland, CaliforniaMedtech
5 sources
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The release announces a $100M credit facility separately from the Series C; it does not state the Series C equity amount.
1 source
1 source
The release URL identifies January 13, 2021, while the page displays Published: 2021-01-22; January 13 is treated as the announcement date rather than the later republisher date.
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The release does not disclose the tranche amount or name the existing investors.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series C | $100M incl. grants | 2026-10-22 | not stated | 3 outlets. #87 in Trending |
5 sources [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 2 of 5 sources The release announces a $100M credit facility separately from the Series C; it does not state the Series C equity amount. | ||||
Promaxo builds a compact, point-of-care MRI platform for urologists, hospitals and other care providers to guide prostate biopsies and treatment, with AI and robotics being developed around it.
Promaxo is moving prostate MRI-guided biopsy and treatment toward the point of care: its site says the system is compact and does not require cryogens or RF-shielded rooms, and reports a 77% cancer-detection rate versus 40% for standard-of-care TRUS biopsy. The latest financing is intended to expand manufacturing, reduce backlog and support new regulatory filings, backing the company’s bet that portable MRI combined with AI and robotics can improve access and precision even though its AI and robotic guidance are not yet cleared for commercial use.
Checked against 10 sources today
| Strategic financing strategic financing [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $1.4M | 2022-04-07 | not stated | No recent discussion |
1 source [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: globenewswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| Funding round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $4.2M | 2021-01-13 | Huami | No recent discussion |
1 source [ VERIFIED ] read against 1 source The release URL identifies January 13, 2021, while the page displays Published: 2021-01-22; January 13 is treated as the announcement date rather than the later republisher date. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: businesswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| Series B Series B-1 [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | n/a | 2020-05-28 | Kineticos Disruptor Fund | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source
The release does not disclose the tranche amount or name the existing investors. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]1 page read: promaxo.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]confirmedchecked against 1 source·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Second tranche of Series A | $2.2m | undated | MicroPort Scientific Corporation | |
Also named as backers in company research: MicroPort Scientific Corporation, RocSon Medtech Fund, Almond Tree Capital Fund, Zynext Ventures, National Institutes of Health, National Science Foundation